PubRank

Georges Vassaux

Author PubWeight™ 38.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene. Hum Gene Ther 2002 1.39
2 The biology of the sodium iodide symporter and its potential for targeted gene delivery. Curr Cancer Drug Targets 2010 1.25
3 Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 2008 1.08
4 Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther 2004 1.08
5 Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter. Clin Cancer Res 2009 1.04
6 Visualization of gene expression in the live subject using the Na/I symporter as a reporter gene: applications in biotherapy. Br J Pharmacol 2009 1.01
7 Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Hum Gene Ther 2002 1.00
8 Exploiting synergies between radiation and oncolytic viruses. Curr Opin Mol Ther 2008 0.99
9 Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano/microbubbles and ultrasound. Ultrasound Med Biol 2007 0.99
10 Listeriolysin O expressed in a bacterial vaccine suppresses CD4+CD25high regulatory T cell function in vivo. J Immunol 2007 0.93
11 Cancer-specific transgene expression mediated by systemic injection of nanoparticles. Cancer Res 2009 0.92
12 Oncolytic viruses in radiation oncology. Radiother Oncol 2011 0.92
13 Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses. Cancer Res 2007 0.92
14 Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours. Eur J Nucl Med Mol Imaging 2010 0.92
15 Delivery of Na/I symporter gene into skeletal muscle using nanobubbles and ultrasound: visualization of gene expression by PET. J Nucl Med 2010 0.90
16 Noninvasive imaging of the transcriptional activities of human telomerase promoter fragments in mice. Cancer Res 2004 0.90
17 Recombinant Escherichia coli expressing invasin targets the Peyer's patches: the basis for a bacterial formulation for oral vaccination. Mol Ther 2006 0.89
18 In vivo retargeting of adenovirus type 5 to alphavbeta6 integrin results in reduced hepatotoxicity and improved tumor uptake following systemic delivery. J Virol 2009 0.88
19 Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: implications for sodium iodide symporter gene therapy. Clin Cancer Res 2008 0.88
20 AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice. J Hepatol 2010 0.88
21 Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion? Immunotherapy 2011 0.86
22 Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectors. Cancer Res 2008 0.85
23 Preclinical applications of imaging for cancer gene therapy. Expert Rev Mol Med 2006 0.85
24 The use of molecular imaging of gene expression by radiotracers in gene therapy. Expert Opin Biol Ther 2011 0.85
25 Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair. Mol Ther 2010 0.85
26 Direct comparison of the insulating properties of two genetic elements in an adenoviral vector containing two different expression cassettes. Hum Gene Ther 2004 0.83
27 Uveal vs. cutaneous melanoma. Origins and causes of the differences. Clin Transl Oncol 2008 0.82
28 Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART1 to CD8+ T cells. Int J Cancer 2003 0.81
29 Normalisation to blood activity is required for the accurate quantification of Na/I symporter ectopic expression by SPECT/CT in individual subjects. PLoS One 2012 0.80
30 RILES, a novel method for temporal analysis of the in vivo regulation of miRNA expression. Nucleic Acids Res 2013 0.78
31 Telomerase-driven expression of the sodium iodide symporter (NIS) for in vivo radioiodide treatment of cancer: a new broad-spectrum NIS-mediated antitumor approach. J Clin Endocrinol Metab 2011 0.78
32 Assessment of endostatin gene therapy for familial adenomatous polyposis-related desmoid tumors. Cancer Res 2006 0.78
33 Genetically engineered E. coli as a protein delivery vehicle for killing cancer cells. Discov Med 2004 0.78
34 Sodium iodide symporter: a new strategy to target cancer? Lancet 2003 0.78
35 The immunogenicity of the tumor-associated antigen α-fetoprotein is enhanced by a fusion with a transmembrane domain. J Biomed Biotechnol 2012 0.78
36 Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer. Vaccine 2012 0.78
37 Differential biodistribution of oncolytic poxvirus administered systemically in an autochthonous model of hepatocellular carcinoma. J Gene Med 2011 0.78
38 A non-invasive tissue-specific molecular delivery method of cancer gene therapy. Minim Invasive Ther Allied Technol 2006 0.77
39 In Vivo Noninvasive Imaging for Gene Therapy. J Biomed Biotechnol 2003 0.77
40 Caspase-1 as a radio- and chemo-sensitiser in vitro and in vivo. Int J Mol Med 2006 0.77
41 Therapeutic potential of replication-selective oncolytic adenoviruses on cells from familial and sporadic desmoid tumors. Clin Cancer Res 2008 0.76
42 Adrenal gland infection by serotype 5 adenovirus requires coagulation factors. PLoS One 2013 0.76
43 Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumors. J Immunother 2009 0.76
44 A new transgenic mouse line to image chemically induced p53 activation in vivo. Cancer Sci 2008 0.76
45 In vivo positron emission tomography imaging using the sodium iodide symporter as a reporter gene. Methods Mol Biol 2012 0.75
46 Suicide gene therapy: conversion of ethanol to acetaldehyde mediated by human beta 2 alcohol dehydrogenase. Cancer Gene Ther 2004 0.75